it is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, with antihyperglycemic activity. it is composed of a GLP-1 (7-36) dimer fused to recombinant human albumin. Upon subcutaneous administration, this agent has a half-life of 4-7 days and resists degradation by dipeptidyl peptidase-4 (DPP-4). 
